CASI Pharmaceuticals stock forecast
CASI Pharmaceuticals (ENM) Stock Forecast & Price Target
ENM Analyst Ratings
ENM Stock 12 Month Forecast
Detailed List of Analyst Forecasts
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Sean Lee CFA | H.C. Wainwright | CHF3.36 | buy | ― | Reiterated | 12/09/25 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Sean Lee CFAH.C. Wainwright | BuyReiteratedCHF3.36 | 12/09/25 | ― |
Best Analysts Covering CASI Pharmaceuticals
Copying Sean Lee CFA's trades and holding each position for 3 Months would result in 35.00% of your transactions generating a profit, with an average return of -5.93% per trade.
Copying Sean Lee CFA's trades and holding each position for 1 Year would result in 15.00% of your transactions generating a profit, with an average return of -34.92% per trade.
Copying Sean Lee CFA's trades and holding each position for 2 Years would result in 10.00% of your transactions generating a profit, with an average return of -49.30% per trade.
ENM Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 0 | 0 | 0 | 0 | 0 |
In the current month, ENM has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. ENM average Analyst price target in the past 3 months is ―.
ENM Financial Forecast
ENM Sales Forecast
Next quarter’s sales forecast for ENM is CHF 0 with a range of ― to ―. The previous quarter’s sales results were CHF 8.25M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

